XOFLUZA 40 MG TABLET

BALOXAVIR MARBOXIL
$162.0320per EA

Strength

40 mg/1

Manufacturer

Genentech, Inc.

NDC

50242086001

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

BALOXAVIR MARBOXIL

Approval Type

New Drug (NDA)

FDA Application

NDA210854

On Market Since

10/24/2018

Pharmacological Classes

Chelating Activity
Polymerase Acidic Endonuclease Inhibitor
Polymerase Acidic Endonuclease Inhibitors

Price History

1W

0.0%

1M

-0.1%

3M

-0.8%

6M

-0.1%

1Y

+2.8%

3Y

+9.6%

5Y

N/A

All

+14.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.